Another former OpenAI executive has started a business, founded just this year, valued at 5.8 billion.

What happened: Kevin Weil, former OpenAI chief product officer and VP for science, announced that his AI research startup Warp Sciences has emerged from stealth with a $215 million Series A round. Key numbers: $215 million Series A led by Lightspeed Venture Partners, with IVP, Premji Invest and Lux Why it matters: Warp will not develop drugs itself. It aims to use AI, robots and automated labs to speed up the labor-intensive testing of molecular variants that pharma companies have long outsourced. Lightspeed's Guru Chahal joins the board and said portfolio companies may become customers.

Kevin Weil, former OpenAI chief product officer and VP for science, announced that his AI research startup Warp Sciences has emerged from stealth with a $215 million Series A round.

Warp will not develop drugs itself. It aims to use AI, robots and automated labs to speed up the labor-intensive testing of molecular variants that pharma companies have long outsourced. Lightspeed's Guru Chahal joins the board and said portfolio companies may become customers.